Ikena Oncology Inc (IKNA) — Cash Flow-to-Debt Ratio
Ikena Oncology Inc (IKNA) has a Cash Flow-to-Debt Ratio of -0.33x as of June 2025, meaning its operating cash flow of $-3.42 Million could theoretically repay 0% of its total liabilities ($10.26 Million) in one year. See IKNA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ikena Oncology Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Ikena Oncology Inc across 7 annual periods. Also explore Ikena Oncology Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ikena Oncology Inc (2018–2024)
Year-by-year debt coverage analysis for Ikena Oncology Inc. For market capitalisation and broader financial context, see IKNA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.95x | $-46.00 Million | $15.58 Million | ▲ +17.3% |
| 2023 | -3.57x | $-79.74 Million | $22.34 Million | ▼ -21.8% |
| 2022 | -2.93x | $-74.11 Million | $25.29 Million | ▼ -94.6% |
| 2021 | -1.51x | $-60.25 Million | $40.00 Million | ▼ -973.0% |
| 2020 | -0.14x | $-37.83 Million | $269.45 Million | ▼ -143.2% |
| 2019 | 0.33x | $47.93 Million | $147.44 Million | ▲ +286.3% |
| 2018 | -0.17x | $-11.61 Million | $66.52 Million | — |